Durolax.com.au

Visit durolax.com.au
  • 10 months ago

    Last scanned

  • No data

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Durolax.com.au

Visit durolax.com.au

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals

Boehringer Ingelheim ranks among the world's leading pharmaceutical companies, focusing on prescription medicines, consumer health care, chemicals, biopharmaceuticals and animal health.

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

DNS used with this website include ns1.sanofi-synthelabo.com, ns2.sanofi-synthelabo.com, ns3.sanofi-synthelabo.com, ns4.sanofi-synthelabo.com.

  • 10 months ago

    Last scanned

  • No data

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

  • DNS

    ns1.sanofi-synthelabo.com

    ns2.sanofi-synthelabo.com

    ns3.sanofi-synthelabo.com

    ns4.sanofi-synthelabo.com

No IP whois info

Whois

Domain & Keywords

The registrar of durolax.com.au is AU-NIC. Owner email is not available.

  • research
  • news releases
  • ah
  • animal health
  • Boehringer Ingelheim
  • consumer health care
  • Annual Press Conference 2006
  • CHC
  • clinical trials
  • PM

Websites similar to durolax.com.au